» Articles » PMID: 29097715

Carbon Adsorbents With Dual Porosity for Efficient Removal of Uremic Toxins and Cytokines from Human Plasma

Overview
Journal Sci Rep
Specialty Science
Date 2017 Nov 4
PMID 29097715
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The number of patients with chronic kidney disease increases while the number of available donor organs stays at approximately the same level. Unavoidable accumulation of the uremic toxins and cytokines for these patients comes as the result of malfunctioning kidneys and their high levels in the blood result in high morbidity and mortality. Unfortunately, the existing methods, like hemodialysis and hemofiltration, provide only partial removal of uremic toxins and/or cytokines from patients' blood. Consequently, there is an increasing need for the development of the extracorporeal treatments which will enable removal of broad spectrum of uremic toxins that are usually removed by healthy kidneys. Therefore, in this work we developed and tested ordered mesoporous carbons as new sorbents with dual porosity (micro/meso) that provide selective and efficient removal of a broad range of uremic toxins from human plasma. The new sorbents, CMK-3 are developed by nanocasting methods and have two distinct pore domains, i.e. micropores and mesopores, therefore show high adsorption capacity towards small water soluble toxins (creatinine), protein-bound molecules (indoxyl sulfate and hippuric acid), middle molecules (β-2-microglobulin) and cytokines of different size (IL-6 and IL-8). Our results show that small amounts of CMK-3 could provide selective and complete blood purification.

Citing Articles

Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease.

Sanchez-Ospina D, Mas-Fontao S, Gracia-Iguacel C, Avello A, Gonzalez de Rivera M, Mujika-Marticorena M J Clin Med. 2024; 13(5).

PMID: 38592263 PMC: 10934686. DOI: 10.3390/jcm13051428.


Hemocompatibility of β-Cyclodextrin-Modified (Methacryloyloxy)ethyl Phosphorylcholine Coated Magnetic Nanoparticles.

Li S, Ghaffari Sharaf M, Rowe E, Serrano K, Devine D, Unsworth L Biomolecules. 2023; 13(8).

PMID: 37627230 PMC: 10452919. DOI: 10.3390/biom13081165.


Hierarchically structural layered double oxides with stretchable nanopores for highly effective removal of protein-bound uremic toxins.

Ding S, Wang D, Wang X Sep Purif Technol. 2022; 301:122033.

PMID: 36071792 PMC: 9436783. DOI: 10.1016/j.seppur.2022.122033.


The Dual Roles of Protein-Bound Solutes as Toxins and Signaling Molecules in Uremia.

Masereeuw R Toxins (Basel). 2022; 14(6).

PMID: 35737063 PMC: 9230939. DOI: 10.3390/toxins14060402.


Research progress on the relationship between IS and kidney disease and its complications.

Gao Y, Li Y, Duan X, Wang Q, Zhang H Int Urol Nephrol. 2022; 54(11):2881-2890.

PMID: 35488145 DOI: 10.1007/s11255-022-03209-1.


References
1.
Meyer T, Peattie J, Miller J, Dinh D, Recht N, Walther J . Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol. 2007; 18(3):868-74. DOI: 10.1681/ASN.2006080863. View

2.
Pavlenko D, van Geffen E, van Steenbergen M, Glorieux G, Vanholder R, Gerritsen K . New low-flux mixed matrix membranes that offer superior removal of protein-bound toxins from human plasma. Sci Rep. 2016; 6:34429. PMC: 5050520. DOI: 10.1038/srep34429. View

3.
Song M, Winchester J, Albright R, Capponi V, Choquette M, Kellum J . Cytokine removal with a novel adsorbent polymer. Blood Purif. 2004; 22(5):428-34. DOI: 10.1159/000080235. View

4.
Meert N, Eloot S, Waterloos M, Van Landschoot M, Dhondt A, Glorieux G . Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant. 2008; 24(2):562-70. DOI: 10.1093/ndt/gfn522. View

5.
Harm S, Falkenhagen D, Hartmann J . Pore size--a key property for selective toxin removal in blood purification. Int J Artif Organs. 2014; 37(9):668-78. DOI: 10.5301/ijao.5000354. View